Dr. Hönle AG

XTRA:HNL Stock Report

Market Cap: €45.6m

Dr. Hönle Past Earnings Performance

Past criteria checks 0/6

Dr. Hönle's earnings have been declining at an average annual rate of -70.3%, while the Electrical industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 0.2% per year.

Key information

-70.3%

Earnings growth rate

-70.6%

EPS growth rate

Electrical Industry Growth30.3%
Revenue growth rate0.2%
Return on equity-5.7%
Net Margin-5.4%
Next Earnings Update30 Jan 2025

Recent past performance updates

Recent updates

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Revenue & Expenses Breakdown

How Dr. Hönle makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XTRA:HNL Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2499-5400
31 Mar 24101-14410
31 Dec 23103-14410
30 Sep 23106-11400
30 Jun 23109-10410
31 Mar 23109-1400
31 Dec 221131400
30 Sep 221163400
30 Jun 22118-3410
31 Mar 22118-3420
31 Dec 21119-3420
30 Sep 21115-5410
30 Jun 211076370
31 Mar 211016350
31 Dec 20955340
30 Sep 20946340
30 Jun 20988370
31 Mar 2010310370
31 Dec 1910310370
30 Sep 1910812370
30 Jun 1911917380
31 Mar 1912218390
31 Dec 1812721390
30 Sep 1812722380
30 Jun 1811919360
31 Mar 1811617350
31 Dec 1711014350
30 Sep 1710210340
30 Jun 17978340
31 Mar 17969340
31 Dec 16938330
30 Sep 16948330
30 Jun 16949320
31 Mar 16939320
31 Dec 159310310
30 Sep 159310310
30 Jun 15888300
31 Mar 15868300
31 Dec 14846290
30 Sep 14826290
30 Jun 14808290
31 Mar 14827290
31 Dec 13817280

Quality Earnings: HNL is currently unprofitable.

Growing Profit Margin: HNL is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HNL is unprofitable, and losses have increased over the past 5 years at a rate of 70.3% per year.

Accelerating Growth: Unable to compare HNL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HNL is unprofitable, making it difficult to compare its past year earnings growth to the Electrical industry (4.1%).

Return on Equity

High ROE: HNL has a negative Return on Equity (-5.69%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 13:24
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Hönle AG is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tim WunderlichHauck Aufhäuser Investment Banking
Alina KohlerHauck Aufhäuser Investment Banking
Anish DixitVirtua Research Inc.